Product Overview

Alternative Name: Ulipristal acetate (UPA) Intrauterine System (IUS)

Development Status: Active Development

Target: Female

Mode: Hormonal

Delivery Type: Intrauterine

Duration Type: Long-acting

Description: UPA is a selective progesterone receptor modulator, released via an intrauterine system.

Updated date: May 30, 2018

Vertical Tabs


Project Phase: Early Development

Project Stage: Pre-clinical

Began discovery in: 2013

Status Details:
  • Prototypes are being designed and developed first for a preclinical toxicology study. This will be followed by development of GMP material for a first proof-of concept clinical trial.

Download Product Report